A Discussion of Contemporary Nomenclature, Diagnosis, Imaging, and Management of Patients With Hypertrophic Cardiomyopathy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  American Journal of Cardiology

• Publication date

  2016-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjcard.2016.08.086PMID 27863696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Misconceptions and Facts About Hypertrophic Cardiomyopathy.

  2016cited by this paper
• Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy.

  2016cited by this paper
• What Do Patients With Hypertrophic Cardiomyopathy Die from?

  2016cited by this paper
• Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies

  2016cited by this paper
• Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States.

  2016cited by this paper
• The Remarkable 50 Years of Imaging in HCM and How it Has Changed Diagnosis and Management: From M-Mode Echocardiography to CMR.

  2016cited by this paper
• How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice.

  2016influential reference
• Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy.

  2016cited by this paper
• Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction.

  2015cited by this paper
• Hypertrophic Cardiomyopathy in Adulthood Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.

  2015influential reference
• Historical perspectives on the implantable cardioverter-defibrillator and prevention of sudden death in hypertrophic cardiomyopathy.

  2015cited by this paper
• New perspectives on the prevalence of hypertrophic cardiomyopathy.

  2015cited by this paper
• Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.

  2014influential reference
• Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

  2014cited by this paper
• [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy].

  2014cited by this paper
• 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

  2014cited by this paper
• Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy ≥60 Years of Age

  2013cited by this paper
• Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

  2013cited by this paper
• Sigmoid shaped interventricular septum exhibit normal myocardial characteristics and has a relationship with aging, ascending aortic sclerosis and its tilt to left ventricle.

  2013cited by this paper
• Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.

  2012cited by this paper
• Hypertrophic cardiomyopathy with longevity to 90 years or older.

  2012cited by this paper
• HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

  2011cited by this paper
• 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cited by this paper
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cited by this paper
• HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

  2011cited by this paper
• 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci

  2011cited by this paper
• Identification of unexpected nonatherosclerotic cardiovascular disease with coronary CT angiography.

  2009cited by this paper
• How should hypertrophic cardiomyopathy be classified?: What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy.

  2009cited by this paper
• Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.

  2009cited by this paper
• Myths about surgical myectomy: rumors of its death have been greatly exaggerated.

  2008cited by this paper
• Use of tissue Doppler to distinguish discrete upper ventricular septal hypertrophy from obstructive hypertrophic cardiomyopathy.

  2008cited by this paper
• Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

  2007cited by this paper
• Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy

  2006cited by this paper
• Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction

  2006cited by this paper
• Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.

  2005cited by this paper
• Clinical course of hypertrophic cardiomyopathy with survival to advanced age.

  2003cited by this paper
• American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G

  2003cited by this paper
• Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

  1995cited by this paper
• Preparticipation echocardiographic screening for cardiovascular disease in a large, predominantly black population of collegiate athletes.

  1989cited by this paper
• Hypertensive hypertrophic cardiomyopathy of the elderly.

  1985cited by this paper
• Patterns of systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: assessment by two-dimensional echocardiography.

  1984cited by this paper
• Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy.

  1983cited by this paper
• Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients.

  1981cited by this paper
• Hypertrophic cardiomyopathy: a discussion of nomenclature.

  1979cited by this paper
• Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients.

  1979cited by this paper
• Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study.

  1976cited by this paper
• Asymmetric Septal Hypertrophy: Echocardiographic Identification of the Pathognomonic Anatomic Abnormality of IHSS

  1973cited by this paper
• Ultrasound Localization of Left Ventricular Outflow Obstruction in Hypertrophic Obstructive Cardiomyopathy

  1969cited by this paper

• Surgical Outcomes of Septal Myectomy With and Without Mitral Valve Surgeries in Hypertrophic Cardiomyopathy: a National Propensity-Matched Analysis (2005 to 2020).

  2023cites this paper
• Contemporary Surgical Management of Hypertrophic Cardiomyopathy.

  2023cites this paper
• The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy

  2021cites this paper
• Hypertrophic Cardiomyopathy

  2020cites this paper
• Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy

  2019cites this paper
• Syndrome of Primary Myocardial Hypertrophy: Clinical and Morphological, Genetic Diagnostics and Comparison of Sarcomerial Variants of Cardiomyopathy and its Phenocopy

  2019cites this paper
• Génétique des cardiomyopathies héréditaires

  2018cites this paper
• Surgical Approaches to Hypertrophic Cardiomyopathy and Implications for Perioperative Management

  2018cites this paper
• ACUTE DECOMPENSATION OF HYPERTENSIVE HEART DISEASE IN PATIENT WITH MALIGNANT URINARY BLADDER PARAGANGLIOMA: STAGES OF DIAGNOSTICS AND TREATMENT

  2018cites this paper
• Cardiac Disease and Pregnancy

  2018cites this paper
• Pediatric Cardiomyopathies.

  2017cites this paper
• Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes

  2017influential citation
• Investigations into the Sarcomeric Protein and Ca2+-Regulation Abnormalities Underlying Hypertrophic Cardiomyopathy in Cats (Felix catus)

  2017cites this paper
• High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy

  2017cites this paper
• How to Image Hypertrophic Cardiomyopathy.

  2017cites this paper